Skip to content
SBI Life Insurance logo

SBI Life Insurance Company

SBILIFE NSE
₹1,710.20 No trade today
P/E
64.61
View as Markdown
MCP
Close 4 Nov 2026 ₹1,710.20 −260.60 −13.2% 1Y
Start ₹1,970.80

Key Fundamentals

LargecapInsuranceFinancial Services

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
15.00%
Debt to Equity
0.00
EPS (TTM)
₹26.47
Book Value
₹204.69
Market Cap
—
P/E (TTM)
64.61
P/B
8.36
ROE
13.70%
Dividend Yield
0.16%
EBITDA
₹2,813 Cr
52W High
₹2,132.00
52W Low
₹1,607.70
Volume
0

Peer Comparison

Financial Services › Insurance › Life Insurance

SBI Life Insurance peer comparison
LIC of India
₹408.008.59₹5,11,882 Cr2.912.53%37.80%35.10%₹9,94,088 Cr₹60,055 Cr
SBI Life Insurance (this company)
₹1,710.2064.61₹1,69,937 Cr8.360.16%13.70%15.00%₹1,21,160 Cr₹2,656 Cr
HDFC Life Insurance
₹532.5056.29₹1,15,614 Cr5.940.40%11.30%10.30%₹1,07,513 Cr₹2,048 Cr
Max Financial Services
₹1,244.30390.06₹41,931 Cr7.510.00%1.52%2.87%₹49,822 Cr₹137 Cr
Canara HSBC Life Insurance Company
₹122.8987.16₹11,515 Cr7.120.33%8.11%8.35%₹12,482 Cr₹134 Cr
Median 5 companies₹532.5064.61₹1,15,614 Cr7.120.33%11.30%10.30%₹1,07,513 Cr₹2,048 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

46 Average

Data confidence 97/100

Category scores

Quality
66
Good
Returns, margins, earnings quality 22% weight
Valuation
30
Poor
Cheap vs sector & own history 24% weight
Growth
56
Good
Sales & profit trajectory 9% weight
Financial Health
73
Strong
Solvency, leverage, coverage 9% weight
Momentum
25
Poor
Trend strength, vol-adjusted 12% weight
Ownership
48
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company is expected to give good quarter

Weaknesses

5
  • Stock is trading at 8.10 times its book value
  • The company has delivered a poor sales growth of 6.52% over past five years.
  • Tax rate seems low
  • Earnings include an other income of Rs.2,003 Cr.
  • Dividend payout has been low at 12.2% of profits over last 3 years

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish739
OscillatorsNeutral333
Moving AveragesStrong Bullish406

Key readings

RSI (14)
56.56
Neutral
MACD (12,26,9)
−11.05
Bullish
SMA (50)
1,705.92
Bullish
SMA (200)
1,842.84
Bearish

As of

Analyst Rating

Based on 34 analysts
BUY97%

33 of 34 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
33
97%
HOLD
1
3%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+19.24%
5Y+6.52%
3Y+11.68%
1Y−3.91%
TTM+16.45%

Net profit

Net profit growth by window
10Y+11.34%
5Y+11.15%
3Y+12.80%
1Y+2.36%
TTM+8.23%

Operating cash flow

Operating cash flow growth by window
10Y+19.57%
5Y+7.65%
3Y+6.41%
1Y+35.14%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−3.99 pp
5Y−0.29 pp
3Y−1.61 pp
1Y−0.44 pp
TTM−0.55 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹30,548 Cr
Mar 2018₹34,068 Cr
Mar 2019₹44,604 Cr
Mar 2020₹43,798 Cr
Mar 2021₹81,913 Cr
Mar 2022₹82,983 Cr
Mar 2023₹80,636 Cr
Mar 2024₹1,31,988 Cr
Mar 2025₹1,16,888 Cr
Mar 2026₹1,12,315 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹955 Cr
Mar 2018₹1,150 Cr
Mar 2019₹1,327 Cr
Mar 2020₹1,422 Cr
Mar 2021₹1,456 Cr
Mar 2022₹1,506 Cr
Mar 2023₹1,721 Cr
Mar 2024₹1,894 Cr
Mar 2025₹2,413 Cr
Mar 2026₹2,470 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EPS
₹7.08 +29.3% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 30 Oct 2026
AI opinion · based on fundamentals
Risk medium

SBI Life Insurance trades at a PE of 63.96 and a PB of 8.1 as of 2026-10-30, with a market cap of ₹1,66,425 Cr. The company is virtually debt-free with a debt-to-equity ratio of 0, but TTM sales growth has turned negative at -1% and TTM profit growth has slowed to 5%, while the stock sits about 22% below its 52-week high of ₹2,132.

Bull Case 6
  • The company is almost debt-free with a debt-to-equity ratio of 0, providing significant financial flexibility and balance sheet strength in a capital-intensive industry.
  • Compounded profit growth of 13% over the last 3 years and 11% over 10 years demonstrates a consistent long-term earnings track record.
  • Return on equity has been steady at 14% over the last 1, 3, and 5 years, indicating disciplined capital allocation relative to insurance sector peers.
  • Compounded sales growth of 19% over the past 10 years reflects the company's ability to scale its premium base over long periods, benefiting from India's underpenetrated life insurance market.
  • The company is expected to deliver a good upcoming quarter, suggesting near-term operational momentum.
  • SBI Life's parentage under State Bank of India provides an unmatched bancassurance distribution network, supporting the 12% compounded sales CAGR over 3 years.
Bear Case 8
  • The stock trades at a PE of 63.96 on a TTM basis, a steep premium that leaves limited room for earnings disappointment.
  • Price-to-book ratio of 8.1 is elevated; the stock is trading at over 8 times its book value, which is expensive even by insurance sector standards.
  • TTM sales growth has turned negative at -1%, a sharp deceleration from the 3-year compounded sales growth of 12%, raising questions about near-term premium momentum.
  • TTM profit growth has slowed to just 5%, down from 13% over 3 years, suggesting earnings momentum is fading.
  • Dividend payout has been low at 12.2% of profits over the last 3 years, with a current yield of just 0.16%, offering minimal income return to shareholders.
  • Earnings include other income of ₹1,991 Cr, which may not be recurring and could overstate core operating profitability.
  • The 5-year compounded sales growth of only 7% and a poor 5-year sales CAGR of 6.52% indicate structural challenges in sustaining top-line expansion.
  • The stock has delivered a negative 1-year return of -10%, underperforming broader markets and signalling weakening investor sentiment.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

9h ago

TL;DR: SBI Life shows solid underlying growth with VoNB up 19% and H1 PAT up 17%, but the headline Q2 profit miss versus estimates is a near-term overhang. First-year premium growth of just 2.1% in September suggests some softness in new business acquisition. Management's reaffirmed guidance of 14-15% retail premium growth and 26-28% VoNB margin provides a constructive forward outlook, though execution in H2 will be key to restoring market confidence.

Headwinds 1
  • Q2 profit misses estimates Nov 3

    Q2FY27 net profit of ₹549.23 crore missed the market estimate of ₹724 crore by a wide margin, despite growing 11% YoY.

Positives 4
  • VoNB up 19% with strong margin Nov 3

    Value of New Business grew 19% YoY to ₹32.7 billion in H1FY27 with a margin of 27.9%, within the guided range of 26-28%.

  • H1 PAT up 17%, 39% ex-GST Nov 3

    H1FY27 profit after tax grew 17% YoY to ₹12.7 billion; excluding the GST impact, PAT growth would have been 39%.

  • 14-15% premium growth guidance held Nov 3

    Management reiterated FY27 retail premium growth guidance of 14-15% and VoNB margin guidance of 26-28%, signaling confidence in the growth trajectory.

Neutral 2
  • New independent director proposed Nov 3

    Shareholder approval sought for Nihar Niranjan Jambusaria as Independent Director for a three-year term from Sep 22, 2026 to Sep 21, 2029, with e-voting open Nov 4 to Dec 3, 2026.

  • First-year premium up 2.1% Oct 8

    First-year premium came in at ₹40.35 billion in September, up a modest 2.1% YoY, reflecting slower new business momentum.

Quarterly Results

₹ Cr
SBILIFE quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
28,805
39,033
36,255
34,654
40,302
18,862
23,071
38,996
23,115
46,133
4,071
46,337
24,620
Expenses
28,392
38,681
37,043
34,060
39,696
18,266
23,520
38,333
22,600
45,517
5,117
45,579
24,058
Operating Profit
413
352
−788
594
606
596
−449
664
516
615
−1,046
757
562
OPM %
1.4%
0.9%
−2.2%
1.7%
1.5%
3.2%
−1.9%
1.7%
2.2%
1.3%
−26%
1.6%
2.3%
Other Income
12
18
1,639
3
−4
−3
1,350
−8
16
27
1,913
36
28
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
424
370
851
597
601
594
901
656
532
642
867
793
590
Tax %
10%
13%
5%
13%
12%
7%
10%
9%
7%
10%
7%
9%
7%
Net Profit
380
322
811
520
529
551
814
594
495
577
805
725
549
EPS (₹)
3.8
3.21
8.1
5.19
5.28
5.5
8.12
5.93
4.93
5.75
8.02
7.23
5.47

Profit & Loss

₹ Cr
SBILIFE profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
23,299
19,324
30,548
34,068
44,604
43,798
81,913
82,983
80,636
1,31,988
1,16,888
1,12,315
1,21,160
Expenses
22,505
18,404
29,479
32,736
43,130
42,447
81,040
82,254
78,713
1,29,884
1,15,469
1,11,451
1,20,271
Operating Profit
794
920
1,068
1,332
1,474
1,351
872
730
1,923
2,104
1,420
864
889
OPM %
3.4%
4.8%
3.5%
3.9%
3.3%
3.1%
1.1%
0.9%
2.4%
1.6%
1.2%
0.8%
0.7%
Other Income
183
129
139
156
266
529
867
1,032
51
50
1,357
1,948
2,003
Interest
4
5
5
6
8
0
0
0
0
0
0
0
0
Depreciation
34
37
48
59
92
89
99
75
68
76
84
115
0
PBT
939
1,007
1,154
1,422
1,642
1,790
1,640
1,687
1,906
2,078
2,693
2,697
2,892
Tax %
13%
16%
17%
19%
19%
21%
11%
11%
10%
9%
10%
8%
—
Net Profit
815
844
955
1,150
1,327
1,422
1,456
1,506
1,721
1,894
2,413
2,470
2,656
EPS (₹)
8.15
8.44
9.55
11.5
13.27
14.22
14.56
15.05
17.19
18.91
24.08
24.63
26.47
Div. Payout %
15%
14%
16%
17%
15%
0%
17%
13%
15%
14%
11%
11%
—

Balance Sheet

₹ Cr
SBILIFE balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,001
1,001
1,002
1,003
1,003
Reserves
3,056
3,733
4,552
5,528
6,576
7,743
9,400
10,622
12,017
13,907
15,983
18,083
19,536
Borrowings
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
70,064
78,696
96,687
1,15,193
1,39,157
1,56,837
2,16,430
2,61,715
3,01,582
3,83,369
4,40,110
4,80,960
5,17,836
Total Liabilities
74,121
83,429
1,02,240
1,21,720
1,46,734
1,65,580
2,26,830
2,73,337
3,14,599
3,98,277
4,57,095
5,00,046
5,38,375
Fixed Assets
292
301
507
511
563
568
564
919
520
551
580
647
735
CWIP
7
146
31
70
32
13
1
3
1
6
10
41
0
Investments
69,385
77,843
95,830
1,14,436
1,39,325
1,58,813
2,18,756
2,64,437
3,04,334
3,85,590
4,47,467
4,86,367
5,26,359
Other Assets
4,437
5,139
5,871
6,703
6,814
6,186
7,509
7,978
9,743
12,130
9,038
12,991
11,281
Total Assets
74,121
83,429
1,02,240
1,21,720
1,46,734
1,65,580
2,26,830
2,73,337
3,14,599
3,98,277
4,57,095
5,00,046
5,38,375

Cash Flow

₹ Cr
SBILIFE cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2,711
5,778
8,525
10,395
13,473
19,299
23,878
21,852
28,656
29,122
25,547
34,523
Investing
−178
−7,204
−9,032
−8,910
−13,552
−16,986
−19,203
−21,611
−30,203
−31,221
−21,789
−35,318
Financing
−117
−144
−144
−221
−241
−198
3
−231
−415
−227
−215
−179
Net Cash Flow
2,416
−1,570
−651
1,264
−321
2,114
4,677
10
−1,962
−2,327
3,543
−974
Free Cash Flow
2,687
5,600
8,377
10,288
13,325
19,210
23,763
21,785
28,581
29,008
25,441
34,338
CFO/EBITDA
341
628
798
780
955
1,473
2,802
3,094
1,532
1,426
1,870
4,112

Ratios

SBILIFE financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
0
0
0
0
0
0
0
0
0
0
Cash Conversion Cycle
0
0
0
0
0
0
0
0
0
0
0
0
Working Capital Days
0
−6
3
3
4
11
1
−3
1
4
2
4
ROCE %
25%
23%
23%
24%
22%
22%
17%
15%
15%
15%
17%
15%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view SBI Life Insurance insights

36 extracted metrics across FY14–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 55.31%
  • FIIs 20.68%
  • DIIs 20.07%
  • Others 2.03%
  • Public 1.91%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about SBI Life Insurance Company

What does SBI Life Insurance Company Ltd do?
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.
Where is SBI Life Insurance Company Ltd (SBILIFE) listed?
SBI Life Insurance Company Ltd trades as SBILIFE on the NSE and under code 540719 on the BSE.
Which sector does SBI Life Insurance Company Ltd belong to?
SBI Life Insurance Company Ltd is classified under the Financial Services sector, in the Insurance industry.
What is the PE ratio of SBI Life Insurance Company Ltd?
SBI Life Insurance Company Ltd trades at a PE ratio of 64.61 as of 4 Nov 2026, on earnings per share of ₹26.47, against a book value of ₹204.69 per share.
What is the 52-week high and low of SBI Life Insurance Company Ltd?
Over the last 52 weeks SBI Life Insurance Company Ltd has traded between ₹1,607.7 and ₹2,132 as of 4 Nov 2026.
Does SBI Life Insurance Company Ltd pay dividends?
SBI Life Insurance Company Ltd has a dividend yield of 0.16%.
What is the Return on Equity (ROE) of SBI Life Insurance Company Ltd?
SBI Life Insurance Company Ltd reported a return on equity of 13.70%. Its debt-to-equity ratio is 0.00.

Company Information

SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.

Website sbilife.co.in
CEO Mr. Amit Jhingran
Employees 25,672
Listed 3 Oct 2017
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SBILIFE.md for SBI Life Insurance Company Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Insurance stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month